Skip to content
Parker Institute for Cancer Immunotherapy
Search
Search Close

Weill Cornell Medicine

Weill Cornell Medicine is tackling some of the biggest challenges in cancer immunotherapy with the tools and the team to make a real difference.

The PICI Center at Weill Cornell Medicine performs discovery research to guide the development of new immunotherapeutic approaches that will be delivered by a diverse workforce to all populations. Recognizing the tremendous impact that immunotherapy can have in some cancers but also seeing the unmet clinical need in others, the PICI Center at WCM brings together basic scientists studying cancer cell biology with immunologists and T cell engineers to address these needs. This innovative, multi-disciplinary approach to deploying new therapies across a large, diverse catchment area is achieved through the collaboration of scientists and physician-scientists, community outreach professionals, veterinary oncologists and biomedical engineers.

Jedd Wolchok, MD, PhD | Director
Taha Merghoub, PhD | Co-Director